Streetbeat News

Products Services

NBIX

Neurocrine Biosciences announced that their Phase 2 study for Luvadaxistat did not meet its primary endpoint for treating cognitive impairment in schizophrenia. The company will now focus on Phase 3 development of other drugs for schizophrenia and major depressive disorder.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 8:11 pm

IMRX

Immuneering shares rise following positive initial response data from a Phase 2a clinical trial involving IMM-1-104 for pancreatic cancer treatment.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 8:10 pm

IMRX

Immuneering has announced initial Phase 2a data for its treatment IMM-1-104 combined with modified Gemcitabine/Nab-Paclitaxel. The results from the first five patients show a 40% overall response rate (ORR) and an 80% disease control rate.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 8:09 pm

CDTX

Cidara Therapeutics is reducing its workforce by 30% to focus on the clinical development of CD388, a drug candidate for influenza A and B. This strategic move aims to reduce capital needs and prioritize upcoming trials. The company is also pursuing business development for its oncology programs.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 8:09 pm

COIN

Cryptocurrency markets are slightly up as traders anticipate a potential rate cut. Bitcoin, Ethereum, and Dogecoin have seen modest gains. Analysts predict a bullish trend for Bitcoin, with potential upward momentum. Notable developments include Grayscale reviving XRP Trust and Coinbase launching cbBTC.

Portfolio Pulse from Khyathi Dalal

September 12, 2024 | 8:00 pm

PPL

PPL Corporation has secured up to $72 million in federal funding from the U.S. Department of Energy's Office of Clean Energy Demonstrations for a CO₂ capture project at its Louisville, Kentucky facility. The first $4.9 million tranche has been awarded to start Phase 1 activities.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 7:47 pm

FTNT

Fortinet has confirmed unauthorized access to a limited number of files on a third-party cloud-based drive. The company states there is no evidence of malicious activity affecting customers, and its operations, products, and services remain unaffected.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 7:32 pm

BTCUSD

ETHUSD

SPY

Donald Trump is set to launch World Liberty Financial, a new venture focused on cryptocurrency, on X Spaces on September 16 at 8PM. This move indicates Trump's interest in embracing the future with crypto.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 7:27 pm

AAPL

The FDA has approved the first over-the-counter hearing aid software compatible with Apple's AirPods Pro, marking a significant milestone in consumer hearing solutions. This software, known as the Hearing Aid Feature (HAF), allows users to transform their AirPods Pro into a hearing aid, enhancing accessibility for individuals with mild to moderate hearing impairment. The approval is part of broader regulatory changes to improve access to affordable hearing aids.

Portfolio Pulse from Vandana Singh

September 12, 2024 | 7:16 pm

AMZN

CMCSA

DIS

DKNG

FOX

PARA

The second week of the 2024 NFL season features key matchups and media companies poised to benefit from increased viewership. DraftKings provides betting odds, while media companies like Comcast, Disney, Amazon, Paramount Global, and Fox are highlighted for their NFL game broadcasts.

Portfolio Pulse from Chris Katje

September 12, 2024 | 7:10 pm